| Cabozantinib impurity 1 |
卡博替尼杂质1 |
748707-58-6 |
| (4-(Naphthalen-1-yl(phenyl)-amino)phenyl)boronic acid |
(4-(萘-1-基(苯基)氨基)苯基)硼酸 |
717888-41-0 |
| 4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine |
4-(3-(4,4,5,5-四甲基-1,3,2-二氧硼戊烷-2-基)苯基)吡啶 |
1009033-83-3 |
| ethyl 4-chloro-6-methylpyrimidine-5-carboxylate |
4-氯-6-甲基嘧啶-5-甲酸乙酯 |
157981-60-7 |
| 3-BroMo-2-ethylpyridine |
3-溴-2-乙基吡啶 |
38749-81-4 |
| Brexpiprazole N-Oxide |
依匹哌唑氮氧化物 |
1191900-58-9 |
| 3-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyridine |
3-[3-(4,4,5,5-四甲基-1,3,2-二氧代硼戊环-2-基)苯基]吡啶 |
939430-30-5 |
| 2-[(4S)-4-(1,1-diMethylethyl)-4,5-dihydro-2-oxazolyl]-Pyridine |
(S)-4-叔丁基-2-(2-氮苯基)恶唑啉 |
117408-98-7 |
| 3-Bromocyclopent-2-enone |
3-溴-2-环戊烯-1-酮 |
51865-32-8 |
| Formoterol EP Impurity C |
福莫特罗EP杂质C |
1795135-61-3 |
| (4S,4'S)-2,2'-(4,6-Dibenzofurandiyl)bis[4,5-dihydro-4-phenyloxazole] |
(4S,4'S)-2,2'-(4,6-二苯并呋喃二基)双[4,5-二氢-4-苯基恶唑] |
246040-77-7 |
| Formoterol EP Impurity D |
福莫特罗EP杂质D |
1795133-96-8 |
| Formoterol Impurity 13 |
福莫特罗杂质13 |
150513-24-9 |
| 4,4,5,5-tetramethyl-2-(10-(naphthalen-1-yl)anthracen-9-yl)-1,3,2-dioxaborolane |
[10-(1-萘基)-9-蒽]硼酸频哪醇酯 |
1149804-35-2 |
| ethyl 4-hydroxy-6-methylpyrimidine-5-carboxylate |
4-羟基-6-甲基嘧啶-5-羧酸乙酯 |
157981-55-0 |
| 2-AMINO-6-BROMOPYRIDIN-3-OL |
2-氨基-6-溴-3-羟基吡啶 |
934758-27-7 |
| 4-(NAPHTHALEN-1-YL)PHENYLBORONIC ACID |
4-(1-萘基)苯硼酸 |
870774-25-7 |
| 2,2'-Bioxazole, 4,4',5,5'-tetrahydro-4,4'-bis[(1S)-1-methylpropyl]-, (4S,4'S)- |
(4S,4'S)-4,4'-二((S)-仲丁基)-4,4',5,5'-四氢-2,2'-联恶唑 |
133463-89-5 |
| INDEX NAME NOT YET ASSIGNED |
(4S,4'S)-2,2'-(环丁烷-1,1-二基)双(4-异丙基-4,5-二氢噁唑) |
2328084-26-8 |
| Pyrimidine, 2-[(4S)-4-(1,1-dimethylethyl)-4,5-dihydro-2-oxazolyl]- |
(S)-4-(叔丁基)-2-(嘧啶-2-基)-4,5-二氢恶唑 |
2070868-78-7 |
QQ
微信
